Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 451,211
  • Shares Outstanding, K 229,041
  • Annual Sales, $ 1,770 K
  • Annual Income, $ -303,660 K
  • 60-Month Beta 0.80
  • Price/Sales 237.43
  • Price/Cash Flow N/A
  • Price/Book 1.15
Trade INO with:

Options Overview Details

View History
  • Implied Volatility 131.30% ( +2.04%)
  • Historical Volatility 121.29%
  • IV Percentile 78%
  • IV Rank 21.39%
  • IV High 468.60% on 05/11/22
  • IV Low 39.51% on 10/05/21
  • Put/Call Vol Ratio 0.56
  • Today's Volume 2,959
  • Volume Avg (30-Day) 2,208
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 104,011
  • Open Int (30-Day) 94,047

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.30
  • Number of Estimates 5
  • High Estimate -0.23
  • Low Estimate -0.38
  • Prior Year -0.39
  • Growth Rate Est. (year over year) +23.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6000 +17.50%
on 05/11/22
3.0902 -39.16%
on 04/21/22
-1.1600 (-38.16%)
since 04/20/22
3-Month
1.6000 +17.50%
on 05/11/22
4.0000 -53.00%
on 04/05/22
-1.3000 (-40.88%)
since 02/18/22
52-Week
1.6000 +17.50%
on 05/11/22
10.3300 -81.80%
on 06/09/21
-5.2500 (-73.63%)
since 05/20/21

Most Recent Stories

More News
Is This Vaccine Stock in Trouble -- or Ready for a Rebound?

Inovio may be at a turning point.

INO : 1.8800 (-4.57%)
Inovio Pharmaceuticals (INO) Q1 2022 Earnings Call Transcript

INO earnings call for the period ending March 31, 2022.

INO : 1.8800 (-4.57%)
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Lags Revenue Estimates

Inovio (INO) delivered earnings and revenue surprises of -28.57% and 56.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

INO : 1.8800 (-4.57%)
KMDA : 4.63 (-0.96%)
Fulcrum Therapeutics, Inc. (FULC) Reports Q1 Loss, Misses Revenue Estimates

Fulcrum Therapeutics, Inc. (FULC) delivered earnings and revenue surprises of -1.59% and 24.98%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

FULC : 8.51 (-1.50%)
INO : 1.8800 (-4.57%)
Biogen Inc. (BIIB) Q1 Earnings Miss Estimates

Biogen Inc. (BIIB) delivered earnings and revenue surprises of -17.91% and 1.13%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

BIIB : 199.65 (+3.40%)
INO : 1.8800 (-4.57%)
June 10th Options Now Available For Inovio Pharmaceuticals (INO)

Investors in Inovio Pharmaceuticals Inc. saw new options begin trading today, for the June 10th expiration.

INO : 1.8800 (-4.57%)
Repligen (RGEN) Beats Q1 Earnings and Revenue Estimates

Repligen (RGEN) delivered earnings and revenue surprises of 27.78% and 12.45%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

RGEN : 154.53 (-0.06%)
INO : 1.8800 (-4.57%)
2 Contenders in the Coronavirus Vaccine Market -- Are They Buys?

These two companies have been left in the dust. Is it too late for them?

INO : 1.8800 (-4.57%)
VXRT : 3.72 (+5.68%)
Interesting INO Call Options For June 3rd

Investors in Inovio Pharmaceuticals Inc. saw new options become available today, for the June 3rd expiration.

INO : 1.8800 (-4.57%)
Interesting INO Put And Call Options For May 27th

Investors in Inovio Pharmaceuticals Inc. saw new options become available today, for the May 27th expiration.

INO : 1.8800 (-4.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

3rd Resistance Point 2.3100
2nd Resistance Point 2.1800
1st Resistance Point 2.0300
Last Price 1.8800
1st Support Level 1.7500
2nd Support Level 1.6200
3rd Support Level 1.4700

See More

52-Week High 10.3300
Fibonacci 61.8% 6.9951
Fibonacci 50% 5.9650
Fibonacci 38.2% 4.9349
Last Price 1.8800
52-Week Low 1.6000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar